Home

Blog

How People Voted

31% For, 69% Against

Take Action

Alert Your Friends and Colleagues
Write Your Representative in Congress
Save & Share
del.icio.us
Digg
Facebook
Google
Reddit
Yahoo!

H.R. 6568, The Tom Lantos Pulmonary Hypertension Research and Education Act of 2008

  • This item is from the 110th Congress (2007-2008) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.

Version saved on October 3, 2008, 19:32:27, by webmaster:

H.R. 6568 would direct the Secretary of Health and Human Services to encourage research and carry out an educational campaign with respect to pulmonary hypertension.

Detailed Summary

Tom Lantos Pulmonary Hypertension Research and Education Act of 2008 - Expresses the sense of the Congress that: (1) the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health (NIH) and the Director of the National Heart, Lung, and Blood Institute, should continue aggressive work on pulmonary hypertension; and (2) the Director of the Institute should continue research to expand the understanding of the causes of, and to find a cure for, pulmonary hypertension.

Requires inclusion of information on the status of pulmonary hypertension research at NIH in biennial reports to Congress.

Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to carry out an educational campaign to increase public awareness of pulmonary hypertension.

Requires the Secretary, acting through the Administrator of the Health Resources and Services Administration (HRSA) and the Director of CDC, to carry out an educational campaign to increase awareness of pulmonary hypertension among health care providers.

Directs the Comptroller General to study and report to Congress on Medicare and Medicaid coverage standards that apply to patients with pulmonary hypertension, including standards for all therapies approved by the Food and Drug Administration (FDA) for the treatment of pulmonary hypertension.

Status of the Legislation

Latest Major Action: 9/26/2008: Received in the Senate.

Points in Favor

(Log in to edit the wiki and be the first to show why the bill should pass!)

Points Against

(Log in to edit the wiki and be the first to show why the bill should not pass!)

« Return to Revision History.



Cost per :

From the Blog

Silly Season on Capitol Hill

Congress has all the planning skills and foresight of a teenager. Y’know how when mom and dad are coming back from their weekend away, the kid tries to do all the chores for the weekend in the last hour? That’s Congress. So as we wrap up ...

Visitor Comments Comments Feed for This Bill

There are currently no comments for this bill.

RSS Feeds for This Bill

Keep yourself updated on user contributions and debates about this bill! (Learn more about RSS.)